Product containing precisely naloxone hydrochloride 20 milligram and oxycodone hydrochloride 40 milligram/1 each modified-release oral tablet 1 tablet tablet (clinical drug)
| Code | 15852811000001104 |
|---|---|
| Semantic tag | clinical drug |
| Module | uk-clinical |
| Definition | defined |
| Effective time | 20250924 |
776864003Oxycodone + Naloxone
product
10363801000001108Virtual medicinal product
product
38420311000001107Myloxifin 40mg/20mg modified-release tablets (Ridge Pharma Ltd)
real clinical drug
38802811000001102Oxyargin 40mg/20mg modified-release tablets (Viatris UK Healthcare Ltd)
real clinical drug
45689411000001109Oxycodone 40mg / Naloxone 20mg modified-release tablets (Krka UK Ltd)
real clinical drug
42758011000001109Sofonac 40mg/20mg modified-release tablets (G.L. Pharma UK Ltd)
real clinical drug
37391311000001106Targinact 40mg/20mg modified-release tablets (CST Pharma Ltd)
real clinical drug
38169111000001109Targinact 40mg/20mg modified-release tablets (DE Pharmaceuticals)
real clinical drug
15851311000001104Targinact 40mg/20mg modified-release tablets (Napp Pharmaceuticals Ltd)
real clinical drug
43400311000001100Targinact 40mg/20mg modified-release tablets (Necessity Supplies Ltd)
real clinical drug
37704711000001109Targinact 40mg/20mg modified-release tablets (Pilsco Ltd)
real clinical drug
24099711000001102Targinact 40mg/20mg modified-release tablets (Waymade Healthcare Plc)
real clinical drug